<--- Back to Details
First PageDocument Content
Immunosuppressive drug / Mechlorethamine / Alkylation / Cyclophosphamide / Antimetabolite / Cisplatin / Busulfan / Melphalan / Nitrogen mustard / Chemistry / Alkylating antineoplastic agents / Chemotherapy
Date: 2010-03-16 04:01:28
Immunosuppressive drug
Mechlorethamine
Alkylation
Cyclophosphamide
Antimetabolite
Cisplatin
Busulfan
Melphalan
Nitrogen mustard
Chemistry
Alkylating antineoplastic agents
Chemotherapy

Add to Reading List

Source URL: jpkc.pumc.edu.cn

Download Document from Source Website

File Size: 111,00 KB

Share Document on Facebook

Similar Documents

Vergleich der Zytotoxizität von ChAPt-11 und Cisplatin an einer TumorzelllinieZellwachstum (% zur Kontrolle)

DocID: 1vkVQ - View Document

Effect of Pemetrexed Alone or Pemetrexed-Cisplatin Regimens on the Liver and Renal Parameters in Adult Cancer Patients

DocID: 1uZLR - View Document

Phase 1b Trial of Tarextumab (OMP 59R5) (anti-Notch 2/3 antibody) in Combination with Etoposide and Cisplatin (EP) in Patients (pts) with Untreated Extensive-Stage Small-Cell Lung Cancer (ED-SCLC): PINNACLE Study M Cathe

DocID: 1t2mY - View Document

DBCGBehandling med Cisplatin v. metastaserende mamma cancer DANISH BREAST CANCER COOPERATIVE GROUP

DocID: 1sFBW - View Document

TACTIC: Phase 2 trial of panitumumab, cisplatin and gemcitabine in biliary tract cancer The TACTIC trial is helping researchers answer an important health question. It is providing evidence on whether panitumumab (Vectib

DocID: 1sxxH - View Document